Related Experiment Video
Updated: Jul 6, 2026
12:37
Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
Melanocortins and their implication in melanoma.
1Department of Research (ZLF), University Hospital and University Children's Hospital, CH-4059 Basel, Switzerland.
Trends in Endocrinology and Metabolism: TEM
|May 1, 1995
Summary
Melanocortins (MCs) influence skin pigmentation and may play a role in melanoma. Targeting MC1 receptors, found on melanoma cells, offers potential for new diagnostic and therapeutic strategies.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Melanocortins (MCs), including melanocyte-stimulating hormones (MSHs) and ACTH, are peptides derived from pro-opiomelanocortin.
- These pleiotropic molecules have diverse physiological functions, with established roles in melanogenesis.
- Their precise involvement in melanocyte and melanoma cell proliferation and metastasis requires further elucidation.
Purpose of the Study:
- To explore the role of melanocortins and their receptors in melanoma.
- To investigate the potential of MC1 receptor targeted therapies for melanoma.
Main Methods:
- Review of recent advancements in MC receptor cloning and characterization.
- Analysis of studies on MC receptor regulation and MSH antagonists like agouti protein.
- Examination of MC1 receptor expression in melanocytes and melanoma cells.
Main Results:
- Five melanocortin receptor subtypes (MC1-5) have been identified.
- Melanocytes and melanoma cells exclusively express MC1 receptors.
- Agouti protein acts as a natural antagonist for MSH.
Conclusions:
- The exclusive expression of MC1 receptors on melanoma cells provides a specific target.
- Development of targeted MC ligands holds promise for melanoma diagnosis and therapy.
- Further research into MC pathways could lead to novel melanoma treatment strategies.
Related Concept Videos
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...